Celularity Receives $12.2 Million from Sale of New Jersey Net Operating Losses
FLORHAM PARK, N.J., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine...
Month: February 2026
FibroBiologics’ Chairman & CEO Pete O’Heeron Selected to Present at A4LI’s H-SPAN Summit at Georgetown University
HOUSTON, Feb. 10, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with...
RenovoRx Establishes RenovoCath® Medical Advisory Board
Advisory Board Members Will Provide Strategic Clinical Insights to Further Advance the TAMP™ Therapy Platform in Clinical Indications of High...
Oncotelic Therapeutics, Inc. Showcases Multi-Year Execution and Validation, Enters 2026 with Late-Stage Momentum Across Diversified Pipeline
AGOURA HILLS, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- via IBN — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“Oncotelic” or the...
TerrAscend to Host Fourth Quarter and Full Year 2025 Earnings Conference Call
TORONTO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North...
Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium™
Oral presentation highlighted the effect of gemfibrozil on Krabbe disease, one of four LSDs in the upcoming Phase 2 SOTERIA...
Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026
BRISBANE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical...
VirtuAlly Among First in Nation to Deliver Specialized Virtual Nursing in Neonatal Intensive Care Setting
Partnership with MUSC brings virtual nursing to South Carolina’s highest-acuity NICU.CHARLESTON, S.C., Feb. 10, 2026 (GLOBE NEWSWIRE) -- VirtuAlly, a...
Survey Reveals the Hidden Mental & Social Burden of Managing Celiac Disease
More than half of people with celiac say they feel isolated or excluded; a majority admit they avoid restaurants and...
Hans Schambye Appointed as Chief Executive Officer of BOOST Pharma
Hans T. Schambye Chief Executive Officer, BOOST Pharma Advancing development of lead candidate BT-101, a potential disease-modifying treatment for Brittle...
OraSure to Launch OraQuick™ HIV Self-Test in Canada
BETHLEHEM, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home...
Krystal Biotech to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
PITTSBURGH, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that it will report...
Cogent Biosciences Announces Multiple SUMMIT Posters at the 2026 AAAAI Annual Meeting
WALTHAM, Mass. and BOULDER, Colo., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on...
INmune Bio Advances CORDStrom™ Towards UK Marketing Authorization in RDEB
Pre-submission package is a process that facilitates early feedback from the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency...
IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share
Reports record revenue of $22.7 million for the fourth quarter of 2025, an increase of $3.3 million, or 17%, compared...
Mobile-health Network Solutions Launches Otter.SG, an AI-Powered Clinic Operating System for Hybrid Care
Singapore, Singapore--(Newsfile Corp. - February 10, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI...
NCQA Kicks Off Inaugural Learning Collaborative to Measure Patient Engagement
Leading healthcare organizations inform and shape best practices in digital wellness, condition management and patient engagement strategies. WASHINGTON, D.C. /...
Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
SHELTON, CONNECTICUT / ACCESS Newswire / February 10, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"),...
Best Mushroom Extract Supplements in 2026: How Formulations Are Evaluated
How Mushroom Extract Supplements Are Evaluated in 2026 Based on Quality, Transparency, and Formulation CASPER, WY / ACCESS Newswire /...
Aspire Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
Company achieves minimum $1.00 closing bid for 10 consecutive business days; Nasdaq confirms matter is closed ESTERO, FLORIDA / ACCESS...